These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 21425165)

  • 1. Nitrofurantoin-p-aminobenzoic acid cocrystal: hydration stability and dissolution rate studies.
    Cherukuvada S; Babu NJ; Nangia A
    J Pharm Sci; 2011 Aug; 100(8):3233-3244. PubMed ID: 21425165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid.
    Li Z; Matzger AJ
    Mol Pharm; 2016 Mar; 13(3):990-5. PubMed ID: 26837376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cocrystals of acyclovir with promising physicochemical properties.
    Sarkar A; Rohani S
    J Pharm Sci; 2015 Jan; 104(1):98-105. PubMed ID: 25407552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel furosemide cocrystals and selection of high solubility drug forms.
    Goud NR; Gangavaram S; Suresh K; Pal S; Manjunatha SG; Nambiar S; Nangia A
    J Pharm Sci; 2012 Feb; 101(2):664-80. PubMed ID: 22081478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing the solubility of natural compound xanthotoxin by modulating stability via cocrystallization engineering.
    Chen JY; Wu H; Guo CY; Zhu B; Ren GB
    Int J Pharm; 2019 Dec; 572():118776. PubMed ID: 31678374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-Drug Binary Solids of Nitrofurantoin and Trimethoprim: Crystal Engineering and Pharmaceutical Properties.
    Maity DK; Paul RK; Desiraju GR
    Mol Pharm; 2020 Dec; 17(12):4435-4442. PubMed ID: 32941048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acemetacin cocrystals and salts: structure solution from powder X-ray data and form selection of the piperazine salt.
    Sanphui P; Bolla G; Nangia A; Chernyshev V
    IUCrJ; 2014 Mar; 1(Pt 2):136-50. PubMed ID: 25075330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Solid Forms of Nitrofurantoin and 4-Aminopyridine Salt: Influence of Salt Hydration Level on Crystal Packing and Physicochemical Properties.
    Boycov DE; Drozd KV; Manin AN; Churakov AV; Perlovich GL
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36558123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated approach to study the dehydration kinetics of nitrofurantoin monohydrate.
    Koradia V; de Diego HL; Elema MR; Rantanen J
    J Pharm Sci; 2010 Sep; 99(9):3966-76. PubMed ID: 20575054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-state characterization of novel active pharmaceutical ingredients: cocrystal of a salbutamol hemiadipate salt with adipic acid (2:1:1) and salbutamol hemisuccinate salt.
    Paluch KJ; Tajber L; Elcoate CJ; Corrigan OI; Lawrence SE; Healy AM
    J Pharm Sci; 2011 Aug; 100(8):3268-3283. PubMed ID: 21472730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanochemical synthesis of bumetanide-4-aminobenzoic acid molecular cocrystals: a facile and green approach to drug optimization.
    Bruni G; Maietta M; Berbenni V; Mustarelli P; Ferrara C; Freccero M; Grande V; Maggi L; Milanese C; Girella A; Marini A
    J Phys Chem B; 2014 Aug; 118(31):9180-90. PubMed ID: 25062449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of hydrate formation of a pharmaceutical solid by using diffuse reflectance infrared Fourier-transform spectroscopy.
    Kojima T; Yamauchi Y; Onoue S; Tsuda Y
    J Pharm Biomed Anal; 2008 Mar; 46(4):788-91. PubMed ID: 18191525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.
    Basavoju S; Boström D; Velaga SP
    Pharm Res; 2008 Mar; 25(3):530-41. PubMed ID: 17703346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal forms of the hydrogen oxalate salt of o-desmethylvenlafaxine.
    Dichiarante E; Curzi M; Giaffreda SL; Grepioni F; Maini L; Braga D
    J Pharm Pharmacol; 2015 Jun; 67(6):823-9. PubMed ID: 25644936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
    McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A
    Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-state characterization and transformation of various creatine phosphate sodium hydrates.
    Xu Y; Jiang L; Huang Y; Wang JR; Mei X
    J Pharm Sci; 2014 Nov; 103(11):3688-3695. PubMed ID: 25223726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism in sulfadimidine/4-aminosalicylic acid cocrystals: solid-state characterization and physicochemical properties.
    Grossjohann C; Serrano DR; Paluch KJ; O'Connell P; Vella-Zarb L; Manesiotis P; Mccabe T; Tajber L; Corrigan OI; Healy AM
    J Pharm Sci; 2015 Apr; 104(4):1385-98. PubMed ID: 25605031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
    J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural characterization and dissolution profile of mycophenolic acid cocrystals.
    Zeng QZ; Ouyang J; Zhang S; Zhang L
    Eur J Pharm Sci; 2017 May; 102():140-146. PubMed ID: 28254392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and evaluation of miconazole salts and cocrystals for improved physicochemical properties.
    Tsutsumi S; Iida M; Tada N; Kojima T; Ikeda Y; Moriwaki T; Higashi K; Moribe K; Yamamoto K
    Int J Pharm; 2011 Dec; 421(2):230-6. PubMed ID: 21983091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.